TerminatedNot Applicable

Omega-3 Monoglyceride Based Topic Products as Skin Prebiotics for Eczema

Stopped: There has been an important change to the product formulation.

Canada7 participantsStarted 2023-12-20

Plain-language summary

This exploratory study aims to verify the impact on the severity of eczema as well as the prebiotic potential of a daily application of Omega-3 serum and cream on a skin with eczema. This study will also collect data on possible adverse effects of the products. Sixteen participants will be enrolled in this study and will be divided in two groups of 8 subjects that will receive two different treatments for forty-two days. The baseline condition will serve as a control for the effects observed after treatment on the targeted eczema area.

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion criteria

✓. Participant aged of at least 18 years old.
✓. Participant diagnosed with eczema who did not use corticosteroids in the 14 days prior to study day 1;
✓. Available for the entire duration of the study and willing to participate based on the information provided in the ICF duly read and signed by the latter.
✓. Participant without intellectual problems likely to limit the validity of consent to participate in the study and compliance with protocol requirements, having the ability to cooperate adequately, understand and observe the instructions of research staff.

What they're measuring

Impact of treatment on participant's self-assessment of eczema severity

Timeframe: 6 weeks

Quantification by qPCR of the four main bacteria of the skin microbiota at the targeted eczema zone.

Timeframe: 6 weeks

Trial details

NCT IDNCT06155513

SponsorSCF Pharma

Sponsor typeINDUSTRY

Study typeINTERVENTIONAL

Primary completion2025-11-05

View on ClinicalTrials.gov More Eczema trials